Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2017-11-21 18:19:56 UTC
Update Date2022-03-07 03:18:14 UTC
HMDB IDHMDB0240250
Secondary Accession NumbersNone
Metabolite Identification
Common NamePhenyltoloxamine
DescriptionPhenyltoloxamine belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. In humans, phenyltoloxamine is involved in the phenyltoloxamine h1-antihistamine action pathway. Phenyltoloxamine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review very few articles have been published on Phenyltoloxamine.
Structure
Data?1563892737
Synonyms
ValueSource
AntinHMDB
BistriminHMDB
BristaminHMDB
C 5581HHMDB
HistionexHMDB
PRNHMDB
PhenoxadrinHMDB
PhenoxadrineHMDB
PhentoloxamineHMDB
PhenyltoxamineHMDB
PhenyltoloxamineHMDB
Phenyltoloxamine hydrochlorideMeSH, HMDB
N,N-Dimethyl-2-(alpha-phenyl-O-tolyloxy)ethylamineMeSH, HMDB
Chemical FormulaC17H21NO
Average Molecular Weight255.361
Monoisotopic Molecular Weight255.1623143
IUPAC Name[2-(2-benzylphenoxy)ethyl]dimethylamine
Traditional Namephenyltoloxamine
CAS Registry Number92-12-6
SMILES
CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1
InChI Identifier
InChI=1S/C17H21NO/c1-18(2)12-13-19-17-11-7-6-10-16(17)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3
InChI KeyIZRPKIZLIFYYKR-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassDiphenylmethanes
Direct ParentDiphenylmethanes
Alternative Parents
Substituents
  • Diphenylmethane
  • Phenoxy compound
  • Phenol ether
  • Alkyl aryl ether
  • Tertiary aliphatic amine
  • Tertiary amine
  • Ether
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Amine
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.51ALOGPS
logP3.93ChemAxon
logS-3.8ALOGPS
pKa (Strongest Basic)8.78ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area12.47 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity80.28 m³·mol⁻¹ChemAxon
Polarizability29.99 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M-H]-167.5331661259
AllCCS[M+H]+159.80631661259
DeepCCS[M+H]+158.53930932474
DeepCCS[M-H]-156.18130932474
DeepCCS[M-2H]-189.14330932474
DeepCCS[M+Na]+164.63230932474
AllCCS[M+H]+159.832859911
AllCCS[M+H-H2O]+156.032859911
AllCCS[M+NH4]+163.432859911
AllCCS[M+Na]+164.432859911
AllCCS[M-H]-167.532859911
AllCCS[M+Na-2H]-167.332859911
AllCCS[M+HCOO]-167.232859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.6.21 minutes32390414
Predicted by Siyang on May 30, 202211.6767 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.29 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1376.1 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid292.5 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid173.6 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid192.0 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid134.4 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid422.6 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid472.4 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)480.6 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1093.9 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid370.0 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1246.9 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid255.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid345.6 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate317.9 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA241.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water7.9 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PhenyltoloxamineCN(C)CCOC1=CC=CC=C1CC1=CC=CC=C12562.3Standard polar33892256
PhenyltoloxamineCN(C)CCOC1=CC=CC=C1CC1=CC=CC=C11961.7Standard non polar33892256
PhenyltoloxamineCN(C)CCOC1=CC=CC=C1CC1=CC=CC=C11948.1Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental GC-MSGC-MS Spectrum - Phenyltoloxamine EI-B (Non-derivatized)splash10-0a4i-9000000000-4846204db840aa67d3e12017-09-12HMDB team, MONA, MassBankView Spectrum
Experimental GC-MSGC-MS Spectrum - Phenyltoloxamine EI-B (Non-derivatized)splash10-0a4i-9000000000-4846204db840aa67d3e12018-05-18HMDB team, MONA, MassBankView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Phenyltoloxamine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-9310000000-aca16420b31b994473372017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Phenyltoloxamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 10V, Positive-QTOFsplash10-0a4i-2290000000-b209d33964c08b4cd6312017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 20V, Positive-QTOFsplash10-00di-9330000000-bf932229994788386be62017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 40V, Positive-QTOFsplash10-0006-9300000000-a8e2773be1f33eee8f512017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 10V, Negative-QTOFsplash10-0udi-1390000000-a92340da8cccbb6ff2cf2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 20V, Negative-QTOFsplash10-0f89-3940000000-529ec6e73c0e19911b232017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 40V, Negative-QTOFsplash10-000x-9600000000-62cec0cdc570e1dc9b132017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 10V, Positive-QTOFsplash10-0ab9-4190000000-f3496d6ee34be6705f1b2021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 20V, Positive-QTOFsplash10-00di-9000000000-38924d94b42b6335fa1d2021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 40V, Positive-QTOFsplash10-00di-9100000000-a95aaf8ba0dc2eee08cb2021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 10V, Negative-QTOFsplash10-0udi-0490000000-f952c76740c44451a0142021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 20V, Negative-QTOFsplash10-001i-1900000000-5ca4860904a5d521b8d92021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Phenyltoloxamine 40V, Negative-QTOFsplash10-001i-2900000000-6e6e6dbea1a924160dd22021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11160
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID6810
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPhenyltoloxamine
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. HOEKSTRA JB, TISCH DE, RAKIETEN N, DICKISON HL: Pharmacological properties of a new antihistaminic agent, phenyltoloxamine (Bristamin). J Am Pharm Assoc Am Pharm Assoc. 1953 Oct;42(10):587-93. [PubMed:13096396 ]